✨ Medicines Notices




7 MARCH

NEW ZEALAND GAZETTE

593

Product:
Sensodyne Dual Protection - (Fresh Mint with Fluoride)

Active Ingredient(s):
Potassium nitrate 5%w/w
Sodium monofluorophosphate 0.76%w/w
Triclosan 0.3%w/w

Dosage Form:
Toothpaste

New Zealand Sponsor:
Stafford-Miller (NZ) Limited

Manufacturer:
Stafford-Miller (Ireland) Limited, Dungarvan, Co. Waterford, Eire

Product:
Sensodyne Dual Protection - (Gentle Whitening with Fluoride)

Active Ingredient(s):
Potassium nitrate 5%w/w
Sodium fluoride 0.221%w/w
Triclosan 0.3%w/w

Dosage Form:
Toothpaste

New Zealand Sponsor:
Stafford-Miller (NZ) Limited

Manufacturer:
Stafford-Miller (Ireland) Limited, Dungarvan, Co. Waterford, Eire

Dated this 28th day of February 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go1535


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Celebrex

Active Ingredient:
Celecoxib 100mg

Dosage Form:
Capsule

New Zealand Sponsor:
Pharmacia Limited Company trading as Pharmacia

Manufacturer:
Searle Limited, Caguas, Puerto Rico

Product:
Celebrex

Active Ingredient:
Celecoxib 200mg

Dosage Form:
Capsule

New Zealand Sponsor:
Pharmacia Limited Company trading as Pharmacia

Manufacturer:
Searle Limited, Caguas, Puerto Rico

Product:
Minirin

Active Ingredient:
Desmopressin acetate 0.1mg equiv to 0.089mg free base

Dosage Form:
Tablet

New Zealand Sponsor:
Pharmaco (NZ) Limited

Manufacturer:
PolyPeptide Laboratories AB, Limhamm, Sweden

Product:
Minirin

Active Ingredient:
Desmopressin acetate 0.2mg equiv to 0.178mg free base

Dosage Form:
Tablet

New Zealand Sponsor:
Pharmaco (NZ) Limited

Manufacturer:
PolyPeptide Laboratories AB, Limhamm, Sweden

Product:
Zoladex 3.6mg

Active Ingredient:
Goserelin acetate 3.6mg

Dosage Form:
Subcutaneous implant

New Zealand Sponsor:
AstraZeneca Limited

Manufacturer:
AstraZeneca UK Limited, Macclesfield, Cheshire, United Kingdom

Dated this 28th day of February 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go1534


Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981,
I, G. R. Boyd, Chief Advisor, Public Health Directorate,
acting under delegated authority, hereby declare the following:

  1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.

  2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.

  3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 20


Gazette.govt.nz PDF NZ Gazette 2002, No 20





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
28 February 2002
Medicines Act 1981, Sensodyne Dual Protection, New Medicines, Distribution Consent
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
28 February 2002
Medicines Act 1981, Celebrex, Minirin, Zoladex, Changed Medicines, Distribution Consent
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Classification of Medicines

πŸ₯ Health & Social Welfare
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, Classification
  • G. R. Boyd, Chief Advisor, Public Health Directorate